Woodline Partners LP Ab Cellera Biologics Inc. Transaction History

Woodline Partners LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.73 - $4.73 $33,204 - $57,530	12,163 New	12,163 $36,000
Q2 2022 Aug 15, 2022	SELL	$5.72 - $10.65 $783,125 - $1.46 Million	-136,910 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$7.46 - $14.14 $3.98 Million - $7.55 Million	-533,729 Reduced 79.59%	136,910 $1.34 Million
Q4 2021 Feb 14, 2022	BUY	$12.99 - $17.73 $3.56 Million - $4.85 Million	273,823 Added 69.01%	670,639 $9.59 Million
Q2 2021 Aug 16, 2021	BUY	$20.19 - $34.17 $2.87 Million - $4.85 Million	141,914 Added 55.67%	396,816 $8.73 Million
Q1 2021 May 17, 2021	SELL	$23.29 - $53.2 $4.1 Million - $9.37 Million	-176,185 Reduced 40.87%	254,902 $8.66 Million
Q4 2020 Feb 16, 2021	BUY	$39.0 - $58.9 $16.8 Million - $25.4 Million	431,087 New	431,087 $17.3 Million

154

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $841M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.